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Background. Noncommunicable diseases (NCDs) are considered as a global health problem and considered as a public health
priority with the more considerable increasing trend of obesity and cardiometabolic disorders rates in the Middle Eastern countries.
This systematic review aims at assessing the prevalence, incidence rates, and trends, as well as the cost of obesity and related
cardiometabolic disorders in the United Arab Emirates (UAE). Methods. A highly sensitive strategy was used to retrieve original
observational studies, addressing the epidemiology and cost of obesity and related cardiometabolic disorders in the UAE, irrespective
of nationality (nationals and expatriates). The search was conducted on April 4, 2017, within numerous electronic databases and
the grey literature. Standardized and validated methods were used for data extraction and analysis as well as quality assessment.
Results. 6789 records were retrieved, of which 36 were deemed eligible. High prevalence rates were reported for obesity, diabetes,
hypertension, and metabolic syndrome in all studies. However, the deﬁnitions and methods employed by the studies were highly
variable. The risk of bias in the epidemiological studies ranged between low and medium. Only one study reported the cost of illness
for diabetes. In this study, the estimated cost per patient was $2,015 (adjusted to the year 2015), and it became twofold and sixfold
higher in patients with microvascular and macrovascular complications, respectively. Conclusions. Obesity and related cardiometabolic disorders are highly prevalent in the UAE, but quoting a precise prevalence for them is diﬃcult given the methodological heterogeneity of the epidemiological studies addressing them. Nonetheless, we detected a 2-3-fold increase in the
prevalence of overweight and obesity in the UAE between 1989 and 2017. It is hopeful that this systematic review will provide an
insight into direct future studies, especially longitudinal studies exploring obesity and cardiometabolic risks and their costs.

1. Introduction
The global rise in the prevalence rates of obesity, metabolic
syndrome, and diabetes has been linked to recent lifestyle
changes occurring during the past few decades, with the

Middle East in general and the United Arab Emirates (UAE)
in particular demonstrating dramatic increases in those rates
[1]. The UAE has witnessed an economic boom that was
accompanied by rapid urbanization and an inﬂux of expatriate workforce [1]. The combination of these factors
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meant a modern, fast-paced, and technology-driven lifestyle
which, in turn, resulted in a reduction in occupational,
domestic, and leisure-time physical activity [2, 3], as well as
an excessive consumption of calorie-dense, processed, and
prepackaged meals of poor nutritional value [3].
The abovementioned risk factors, in addition to the high
incidence of tobacco use in the UAE, possibly explain the
witnessed increase in obesity and cardiometabolic disorder
rates in the country [4, 5], resulting in increased demand for
disease-speciﬁc health services. A recent systematic review
on the UAE’s health status ranks cardiovascular diseases as
a top public health priority for the country, attributing to it
the majority of noncommunicable disease- (NCD-) related
mortalities [6]. This overlaps with the global epidemiology of
NCDs, among which cardiovascular diseases also rank ﬁrst
in terms of incidence and mortality [7]. In fact, the UAE’s
2021 vision is to adopt the number of deaths due to cardiovascular diseases per 100,000 population, the prevalence
of diabetes, and the prevalence of obesity amongst children
as its primary national performance indicators for a desired
world-class health care, in order to guide targeted interventions and public health eﬀorts [8].
Therefore, the following systematic review provides
a current evidence-based assessment of the epidemiology
and economic burden of obesity and cardiometabolic disorders in the UAE, given the lack of such an assessment. We
hope that our reported data provide an up-to-date epidemiological proﬁle (prevalence, incidence, and trends) for the
country with regard to cardiometabolic disorders and their
associated costs and that this would eventually guide public
health policy-makers in prioritizing and allocating resources
properly for managing and preventing those diseases [9]. We
also hope that our review highlights the current gaps in
relevant research in preparation for subsequent research
eﬀorts.

2. Methods
We followed the standardized methods outlined by Moher
et al. in the PRISMA 2010 group in conducting and reporting
our systematic review [10]. However, we drafted a priori
a protocol for the review and published it in the International Prospective Register of Systematic Reviews
(PROSPERO) (CRD42016035747).
2.1. Database Search. We searched MEDLINE, PubMed,
Embase, Cumulative Index to Nursing and Allied Health
Literature (CINAHL), Index Medicus for the Eastern
Mediterranean Region (IMEMR), ProQuest Dissertations &
Theses Database (PQDT), Open Access Theses and Dissertations (OATD), and Web of Science for studies
addressing the epidemiology and costs of cardiometabolic
disorders in the UAE, using an extensive and highlysensitive search strategy (Appendix A-a in Supplementary
Materials). We replicated the search employing appropriate
and speciﬁcally adapted vocabulary for each of the databases
searched in order to retrieve all potentially eligible references. The initial search was conducted on June 19, 2015, and
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updated on April 4, 2017, to ensure that our review is
current.
2.2. Searching Other Sources. In addition to the above databases, we searched the grey literature, the International
Diabetes Federation (IDF), and primarily the World Bank
websites for additional eligible studies. We also contacted
prominent scholars and experts in the ﬁeld from the UAE to
inquire about any ongoing relevant studies not published
yet.
It is worth mentioning that, in our original search, we
aimed at ﬁnding studies that address the epidemiology and
costs of either cancer and/or cardiometabolic disorders in
the UAE, which are the top two incident NCDs within the
UAE and thus the lead priorities on its public health agenda
[6]. However, given the diﬀerence between the two diseases
with regard to their underlying determinants (i.e., risk
factors) and patient proﬁles and in order to generate diseasespeciﬁc epidemiology and/or cost data for specialized policymakers and researchers in each ﬁeld, we opted to report the
data for each of them in a separate systematic review.
Nonetheless, both reviews were registered with the same
protocol (CRD42016035747).
2.3. Inclusion and Exclusion Criteria. As outlined in our
protocol, studies eligible for inclusion had to meet the
following criteria:
(i) Be original studies (e.g., editorials, case reports, case
series, and reviews were excluded)
(ii) Have an observational design: cohort or crosssectional studies for epidemiological outcomes
and economic models and cross-sectional or longitudinal studies for cost analyses
(iii) Address cardiometabolic disorders deﬁned as cardiovascular diseases of all types, type 2 diabetes,
and/or metabolic syndrome including its primary
components of obesity, insulin resistance, dyslipidemia, and/or hypertension
(iv) Report data speciﬁc for the UAE’s citizens irrespective of their nationality (nationals and/or expatriates), sex (women and/or men), or age
(children and/or adults)
(v) Written in English, Arabic, or French, irrespective
of publication status (published versus unpublished) or date (i.e., no time limit)
2.4. Selection of Studies. Three reviewers (RB, HR, and RR),
assisted by a reference manager (EndNote©), looked for
potentially eligible studies by screening the titles and abstracts of the records retrieved by the search. After conducting a prior calibration exercise to ensure inter-reviewer
screening consistency, two pairs of authors (RB/RR and
HR/HH) individually and in pairs retrieved and evaluated
the full texts of one-half of the references deemed eligible
before (i.e., during the title and abstract screening phase) for
inclusion in data extraction. A screening tool was developed
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by the three reviewers (RB, HR, and RR) and pretested
through a calibration exercise prior to the actual full-text
screening. Disagreements were resolved through discussion
with a third reviewer.
2.5. Data Extraction. The two reviewers in each pair (RB/RR
and HR/HH) individually and in pairs extracted relevant
data from the included studies, consulting a third reviewer
whenever they disagreed. As set in our protocol, the reviewers performed a qualitative (i.e., narrative) synthesis of
the data extracted from the included studies, given that
quantitative synthesis (i.e., meta-analysis) is not possible due
to the epidemiological nature of the data extracted.
2.6. Risk of Bias Assessment. The reviewers used the tool
developed and validated by Hoy et al. [11] to assess the risk
of bias in the included studies. The tool comprises 10 items
that address both the external and internal validity of each
study, with an additional item that provides an overall
summary of the risk of bias in the study. Each item is
categorized as having “high risk,” “intermediate risk,” or
“low risk” of bias, with the overall risk of bias being lower
when more criteria (i.e., items) are adequately met. A high
risk of bias was assigned to studies with unclear or poor
reporting of a particular item. Finally, a study was considered to have an overall high risk of bias when it met less than
5 criteria, moderate risk of bias when it met 5 to 7 criteria,
and low risk of bias when it met 8 or more criteria.

3. Results
Our initial search retrieved 6789 records, of which only 30
were deemed eligible. The updated rerun of the search retrieved 6 additional eligible studies, yielding a total of 36
studies that were eligible and included in data extraction and
synthesis (Appendix A-b in Supplementary Materials).
3.1. Characteristics of Included Studies. Tables 1–3 summarize the characteristics, results, and overall risk of bias in the
included epidemiological studies (n � 35). Table 4 summarizes the characteristics and results of the single study
identiﬁed that addresses the cost of illness (COI) for diabetes
[12]. Included studies addressed various cardiometabolic
disorders, including overweight/obesity (n � 19), metabolic
syndrome (n � 3), dyslipidemia (n � 1), hypertension
(n � 2), diabetes (n � 4; 2 prevalence, 1 incidence, and 1
cost), and multiple cardiometabolic disorders at once
(n � 7). Only one study was a retrospective cohort [13], with
the rest being cross-sectional studies (n � 35). All included
studies were published between 1995 and 2016 (1990–1999:
n � 6; 2000–2009: n � 15; and after 2009: n � 15), reporting
data collected between 1989 and 2015. Half of the included
studies reported data speciﬁc to Emiratis (n � 18), and twothirds (n � 24) reported data for both sexes. Only six studies
were conducted at the national level [3, 14–18], with the rest
being emirate-speciﬁc. Finally, more than half of the included studies used a random sample (n � 20), seven
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recruited a convenient sample, four adopted exhaustive
sampling (census), and one included a purposive sample.
Four studies did not report their sampling method. It is
worth noting that the included studies remarkably varied in
their recruited sample size, ranging from 98 [19] up to
173,501 [20] participants.

4. The Epidemiology of Cardiometabolic
Disorders in the UAE
4.1. Overweight and Obesity
4.1.1. Paediatric Population. Abdulrazzaq et al. (1991-1992)
provided the earliest and most exhaustive national-level
estimates of the prevalence of overweight and obesity in
the Emirati paediatric population, reporting rates of 13% for
boys below the age of 5 and 6% for their female counterparts
[16]. The study reports that these ﬁgures gradually increase
with age, peaking at 18 years. Three other studies address
more recent national estimates for overweight and obesity in
Emirati schoolchildren and adolescents, with a 10-year interval diﬀerence between the two older studies (1998-1999)
[22] and the most recent one (2009-2010) [3]. Despite
reporting similar overweight estimates of about 19% for each
of the boys and the girls and no major diﬀerences in sexspeciﬁc rates, the two older studies [15, 22] remarkably
diﬀered in their reported overall obesity rates (7% [22]
versus 13% [15]). In contrast, the more recent study highlights the emergence of sex-speciﬁc diﬀerences, particularly
in overweight rates in children aged 6 to 10 (24% for girls
versus 9% for boys) and obesity rates in adolescents aged 11
to 18 (20% for girls versus 12% for boys) [3]. The study
reports an overall prevalence of 40% of overweight and
obesity for Emirati female children compared to 25% only
for their male counterparts [3]. The same was reported in
adolescents. On the contrary, at the emirate-speciﬁc level,
Fujairah seems to harbour the highest rates of overweight
and obesity, reporting a striking 30% prevalence among its
Emirati schoolgirls [21]. Two other studies assessed the
prevalence of overweight and obesity in Emirati schoolchildren in Ras Al Khaimah, another emirate, with more
than a decade as the time diﬀerence between the older study
[14] and the recent one [23]. Direct comparison of the results
of these two studies [14, 26] is challenging given their use of
diﬀerent deﬁnitions for overweight and obesity and the
inclusion of children of diﬀerent age groups. However,
despite those diﬀerences, the rates of overweight and obesity
reported by the older study compared to the recent one show
a tremendous increase over time, almost doubling for
overweight (9% versus 17%, respectively) and more than
doubling for obesity (8% versus 20%, respectively). As for
Abu Dhabi, two recent studies report similar rates of approximately 34% of overweight and obesity prevalence
among both Emirati and non-Emirati schoolchildren
[25, 35]. These studies have also employed diﬀerent disease
deﬁnitions and included children of diﬀerent age groups,
which prevented us from providing conclusive evidence
through directly comparing their ﬁndings. However, the two
studies seem to be in agreement with regard to their reported

Obesity in
children

Cross-sectional
Period: October
1998–April 1999

Cross-sectional
Period: October
1998–April 1999

Overweight: BMI ≥ 25 kg/m2 and <30 kg/m2 Obesity:
BMI ≥30 kg/m2 (Cole et al. International Standards for
overweight and obesity)

Overweight: BMI >25 kg/m2 Obesity: BMI >30 kg/m2
(IOTF classiﬁcation)

Al Haddad et al.
(2005) [22]

Malik and Bakir
(2007) [15]

Unclear Sample #: 898

Sampling

Multistage stratiﬁed random
Emirate: Sharjah Nationality: NR Gender: boys: sampling: stage 1: administrative
51.9%; girls: 48.1% Mean age: boys: 16.41 (0.93); regions, stage 2: schools by PPS to
girls: 16.54 (0.99) (range: 15–18 years) Students administrative regions, and stage 3:
in secondary schools (public)
classes (simple random method)
Sample #: 505
Cross-sectional
Period: March
2010–January 2011

Overweight: IOTF reference standard Obesity: IOTF
reference standard

Musaiger et al.
(2012) [26]

Two-stage stratiﬁed sampling by
gender: stage 1: schools; stage 2:
students by PPS Sample #: 1,440

Emirate: Abu Dhabi Nationality: Emirati: 71.9%;
others: 28.1% Gender: girls: 48.9%; boys: 51.1%
Schoolchildren (public) aged 6–19 years

Cross-sectional
Period:
January–December
2011

Overweight: 85th < BMI <95th CDC percentile for age
and sex Obesity: BMI ≥95th CDC percentile for age and
sex

Al Junaibi et al.
(2013) [25]

Multistage stratiﬁed random
sampling (stratiﬁed by sex and
school type: preparatory and
secondary; randomization method
not detailed) Sample #: 661
Emirate: Dubai Nationality: Emirati Gender:
girls: 51%; boys: 49% Age range: 12–17 years
Preparatory and secondary school students
Cross-sectional
Period: NR

Cross-sectional
Period: 2014-2015

Overweight: 85th to <95th BMI percentiles Obesity:
≥95th BMI percentile (WHO, 1995)

Exhaustive (all governmental
schools in Ras Al Khaimah, with
assigned nurses or where
height/weight measurements are
directly supervised) Sample #:
29,410
Emirate: Ras Al Khaimah Nationality: Emirati:
92%; others: 8% Gender: girls: 51%; boys: 49%
Mean age: 10.4 (3.9) (range: 3–18 years)
Schoolchildren (public)

Bin Zaal et al.
(2009) [24]

Unclear Sample #: 4,075

Emirate: Ras Al Khaimah Nationality: Emirati
Gender: girls: 56.1%; boys: 43.9% Schoolchildren
aged 6–16 years

Multistage stratiﬁed random
Emirate: All (national) Nationality: Emirati Age:
sampling (not detailed) Sample #:
0–18 years
20,494

Multistage stratiﬁed cluster
sampling; stage 1: educational
Emirate: All (national) Nationality: Emirati
districts; stage 2: schools by PPS;
Schoolchildren aged 4–18 years
stage 3: all Emirati students Sample
#: 15,989
Two-stage PPS cluster random
sampling: stage 1: schools
Emirate: All (national: Abu Dhabi: 47.2%; Abu
(categorized according to size,
Dhabi (Al Ain): 34.5%; others: 18.3%)
gender, ethnic mix, type, and area
Nationality: Emirati: 48%; others: 52% Gender:
of residence; randomization
boys: 49.6%; girls: 50.4% Schoolchildren (public
method not detailed); stage 2: one
and private) aged 5–17 years
or more whole class per each school
grade (25 children) Sample #: 4,381

Emirate: Abu Dhabi (43.2%), Sharjah (19.2%),
Dubai (16.3%), Ras Al Khaimah (16.1%), and
Fujairah (5.2%) Nationality: Emirati Gender:
female schoolchildren (public) aged 11–18 years

Participant characteristics

Cross-sectional
Period: NR

Cross-sectional
Period: 1991-1992

Cross-sectional
Period: October
1998–April 1999

At risk for overweight: BMI ≥ 85–95th
percentiles for age and sex
Overweight: ≥95th percentile for age and sex
(NHANES reference data)

Al Hourani et al..
(2003) [21]

Overweight: (1) Under 5 years: ≥1 SD (equivalent to BMI
25 kg/m2 at 19 years) (WHO criteria) (2) 18 years old:
Abdulrazzaq et al. IOTF guidelines (3) Other age groups (NR) Obesity: (1)
Under 5 years: ≥2 SD (equivalent to BMI 30 kg/m2 at 19
(2011) [16]
years) (WHO criteria) (2) 18 years old: IOTF guidelines
(3) Other age groups (NR)
Overweight: BMI ≥85th and <95th percentiles for age
Al Haddad et al. and sex Obesity: BMI ≥95th percentile for age and sex or
(2000) [14]
BMI ≥30 kg/m2, whichever is smaller (NHANES
reference data)
Overweight, obesity, and extreme obesity: IOTF (1)
Overweight: BMI ≥25 kg/m2 equivalent and <30 kg/m2
equivalent (2) Obesity: BMI ≥30 kg/m2 equivalent WHO
(1) Overweight: BMI for age ≥85th percentile and <95th
Al Blooshi et al.
percentile (2) Obesity: BMI for age ≥95th percentile
(2016) [23]
CDC (1) Overweight: BMI for age ≥85th percentile and
<95th percentile (2) Obesity: BMI for age ≥95th
percentile

Study type

Studied disease (criteria)

Author
and year

Table 1: Characteristics of included epidemiological studies
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Obesity in
community

Obesity in
university
students

Cross-sectional
Period: NR

Cross-sectional
Period: October
1999–April 2000

Cross-sectional
Period: NR

Overweight: BMI 25–29.9 kg/m2 Obesity: BMI
≥30 kg/m2

Obesity: BMI ≥25 kg/m2

Overweight: BMI 25–29.9 kg/m2 Obesity: BMI
≥30 kg/m2

Overweight: 25 < BMI > 29.9 kg/m2 Obesity: BMI
≥30 kg/m2 (WHO classiﬁcation) Hypertension (NR)
Diabetes (NR)

Overweight: BMI 25–29.9 kg/m2 Obesity: BMI 30+

Badr and ElSabban (2008)
[28]

Musaiger et al.
(2003) [29]

Sheikh-Ismail
et al. (2009) [30]

Kerkadi (2003)
[31]

Musaiger and
Radwan (1995)
[32]

Adults: (1) Overweight: ≥25 BMI <30 kg/m2 (2) Obesity:
Ng et al. (2011) [3] BMI ≥30 kg/m2 (WHO, 2000) Children and adolescents
(<19 years): IOTF cutoﬀs

Overweight (not deﬁned) Obesity (not deﬁned)

Cross-sectional
Period: NR

Overweight: BMI 25–29.0 kg/m2 Obesity: BMI
≥30 kg/m2

Al Mukhtar (2000)
[19]

Papandreou et al.
(2015) [33]

Cross-sectional
Period: NR

Overweight: 110–120% of the reference value for
standard weight for height tables issued by the Nutrition
Institute in Cairo, Egypt Obesity: >120% of the reference
value for standard weight for height tables issued by the
Nutrition Institute in Cairo, Egypt

Amine and Samy
(1996) [27]

Cross-sectional
Period: 2009-2010

Cross-sectional
Period: 2014

Cross-sectional
Period: 1993

Cross-sectional
Period: 1996-1997

Study type

Studied disease (criteria)

Author
and year

Table 1: Continued.

Random sampling (not detailed)
Sample #: 98

Unclear Sample #: 200

Stratiﬁed (according to the number
of students from each Emirate)
random sampling (not detailed)
Sample #: 566 included

Sampling

Emirate: Abu Dhabi (Al Ain) Nationality: NR
Gender: male Age range: 18–24 years Student
residing in hostels related to UAE University

Two-stage random sampling: stage
1: hostels (simple random); stage 2:
students (systematic random)
Sample #: 300
For students: stratiﬁed
proportionately to emirate size and
Emirate: Abu Dhabi (Al Ain) Nationality:
conveniently from university
Emirati from all emirates Gender: female Age:
facilities, cafeteria, student hostels,
20–<30: 44.2%; 30–<60: 49.2%; >60: 6.6%
sports center, library, and classes
Students in UAE University
For their family members: random
(not detailed) Sample #: 724
Emirate: Abu Dhabi (Al Ain) Nationality: NR
Convenient sampling Sample #:
Age range: 18–25 years Students in UAE
400
University
Emirate: Abu Dhabi (Al Ain) Nationality:
Emirati: 91.6%; others: 8.4% Gender: female
Convenient sampling Sample #: 215
Mean age: 19.7 (1.3) (range: 18–30 years)
Students in UAE University
Emirate: NR Nationality: NR Gender: female
Convenient sampling Sample #:
Mean age: 20.55 (2.25) Students in 1 public
243
university
Multistage random sampling: stage
1: census enumeration area in the
urban areas or a village in the rural
areas; stage 2: households
Emirate: All (national) Nationality: Emirati
(randomization method not
Adult women: ≥19 years; adolescents: 11–18
detailed); participants (not
years; children: 6–10 years
detailed) Sample #: households: 628
(adult women: 478; adolescents:
women: 143 and men: 133;
children: women: 126 and men:
127)

Emirate: Abu Dhabi (Al Ain) Nationality:
Emirati (Abu Dhabi: 40.3%, Dubai: 17.5%,
Sharjah: 19.3%, Ras Al Khaimah: 14%, and
others: 9%) Gender: female Students in UAE
University
Emirate: Abu Dhabi (Al Ain) Nationality: NR
Gender: female Age: mean: 19.8 (1.5); groups:
<20 years: 38.5%; ≥20 years: 61.5% Student
residing in hostels related to UAE University
Emirate: Abu Dhabi (Al Ain) Nationality:
Emirati Gender: female: 63.3%; male: 36.7%
Mean age: 20.4 (1.6) (female: 20.0 (1.6); male:
21.03 (1.5)) Students in UAE University

Participant characteristics
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Diabetes

Hypertension

Dyslipidemia

Metabolic
syndrome

Studied disease (criteria)

Study type

Participant characteristics

Sampling

Cross-sectional
Period: September
2000–August 2001

Stratiﬁed multistage random
Emirate: Abu Dhabi (Al Ain) Nationality:
sampling: stage 1: living areas
Carter et al. (2004)
Overweight: BMI 25–29.9 kg/m2 Obesity: BMI
Emirati citizen (by birth: 79%; by marriage: 21%) (randomization unclear); stage 2:
≥30 kg/m2 (NHLBI)
[34]
Gender: female Mean age: 34.3 (14.7)
houses (systematic randomization);
Community-dwelling
stage 3: all women living in chosen
houses Sample #: 535
Metabolic syndrome (IDF deﬁnition) WC ≥90th
Two-stage PPS random sampling:
percentile or ≥94th percentile; cut points for youth aged
Emirate: Abu Dhabi (Al Ain) Nationality:
stage 1: schools (randomly selected
Cross-sectional
Mehairi et al.
≥16, TG ≥150 mg/dL (1.7 mmol/L), HDL-C <40 mg/dL
Emirati: 52%; others: 48% Gender: male: 51.6%; by using SPSS Software); stage 2:
Period: March–April
(2013) [35]
(1.03 mmol/L) or <50 mg/dL (1.29 mmol/L) for female
female: 48.4% Mean age: 15.4 (1.8) (range 12–18 students sampled proportional to
2010
adolescents aged ≥16, FBG >100 mg/dL (5.6 mmol/L),
years) Schoolchildren (public and private)
the enrollment size of each school
and BP ≥130/80 mmHg
(self-weighting) Sample #: 1,018
Metabolic syndrome ≥3 of the following: (1) elevated
WC (≥80 cm); (2) hypertriglyceridemia (TG
Stratiﬁed random sampling:
≥150 mg/dL or drug treatment for elevated TG); (3)
Emirate: Abu Dhabi (Al Ain) Nationality:
stratiﬁcation by college, followed
Al Dhaheri et al.
reduced HDL-C (<50 mg/dL or drug treatment for
Cross-sectional
Emirati Gender: Female Mean age: 20.4 (1.7)
by random subsample of 10% of
(2016) [36]
Period: 2013-2014
reduced HDL-C); (4) elevated BP (SBP >130 mmHg
(range 17–25 years) Students in UAE University
each college (unclear
and/or DBP >85 mmHg or use of antihypertensive
randomization) Sample #: 555
drugs); (5) elevated FBG (≥100 mg/dL or use of
hypoglycemic medication) (IDF and AHA/NHLBI)
Participants recruited from the
Metabolic syndrome: NCEP and IDF deﬁnition
2000 Emirates National Diabetes
(ethnicity-speciﬁc cutoﬀ levels of WC to deﬁne central
Cross-sectional
Emirate: All (national) Nationality: Emirati:
study and screening for risk factors
obesity ≥90 cm for South Asian men and ≥94 cm for
Malik and Razig
42%; others: 58% Gender: male: 41.3%; female: for Coronary Artery Disease Study
Period: October
men from other nationalities; for women, irrespective of
(2008) [17]
Multistage, stratiﬁed, cluster
58.7% Mean age: 41.45 (11.7)
1999–June 2000
ethnicity: ≥ 80 cm; high WHR: ≥0.95 for men and ≥0.90
random sampling (not detailed)
for women)
Sample #: 4,097
Emirate: NR Nationality: UAE nationals: 26.6%; Convenient sampling (recruitment
Dyslipidemia (elevated total cholesterol) Borderline
Cross-sectional
Arabs (non-UAE): 45.9%; non-Arabs: 27.5%
from urban public sites, e.g.,
Agarwal et al.
high: 200–239 mg/dL High: 240 mg/dL (NCEP
(1995) [37]
Period: NR
Gender: female: 24.6%; male: 75.4% Age: <51
shopping malls, mosques, etc.)
guidelines)
years: 85.1%; >51 years: 14.9%
Sample #: 834
Two-stage random sampling: stage
1: public schools (stratiﬁed to
Emirate: Abu Dhabi Nationality: Emirati
collect a similar number of boys
Prehypertension: BP ≥90th and <95th CDC percentiles
Cross-sectional
Abdulle et al.
Gender: female: 47.3%; male: 52.7% Mean age:
and girls); stage 2: students
for age and sex Hypertension: BP ≥95th CDC percentile
Period: January
(2014) [38]
female: 11.0 (3.4); male: 11.7 (3.5) (range 6–17
(proportional to school size)
for age and sex
2011–December 2011
years) Schoolchildren (public)
Sample #: 999 (405 non-Emirati
and 36 Emirati adults were
excluded)
Stratiﬁed (unclear) systematic
Hypertension: SBP >140 mmHg and/or DBP
Emirate: Sharjah Nationality: Emirati Gender:
random sampling (PHC) and
El Shahat et al.
>90 mmHg, and/or self-reported treatment with
Cross-sectional
female: 53%; male: 47% Age: 17–30: 26%; 31–50:
census of governmental
(1999) [39]
antihypertensive medications (JNC-VI on detection,
Period: 1997
46%; >50: 28% (range: 18–75 years)
departments’ employees Sample #:
evaluation, and treatment of high blood pressure)
3,150
Emirate: Abu Dhabi (Al Ain) (Zakher (urban)
Purposive for the locations (to
Diabetes: random BG (taken 2–4 hours after a meal)
Cross-sectional
and Al Hayer and Wagan (rural) areas)
increase the Bedouin-derived
El Mugamer et al.
≥11.1 mmol/L (WHO) Hypertension: SBP >140 mmHg
Period: 1989-1990
Nationality: Emirati Gender: female: 61.8%;
population); unclear for
(1995) [40]
and/or DBP >90 mmHg Obesity: BMI ≥30 kg/m2
male: 38.2% Age: >19 years
participants Sample #: 322

Author
and year

Table 1: Continued.
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Multiple risk
factors

Studied disease (criteria)

Study type

Participant characteristics

Abnormal glucose tolerance: WHO expert group
recommendation Diabetes: FBG ≥7.0 mmol/L and/or
2 h BG ≥11.1 mmol/L Impaired fasting glycemia: FBG:
Malik et al. (2005) 6.1–6.9 mmol/L IGT: 2 h venous BG: 7.8–11.0 mmol/L
[18]
on the OGTT Hypertension: SBP ≥140 mmHg and/or
DBP ≥90 mmHg Central obesity: WHR ≥0.95 for men
and ≥0.90 for women Preobesity: BMI 25–29.9 kg/m2
Obesity: BMI ≥30 kg/m2
Dyslipidemia: history of known or treated dyslipidemia
(receiving cholesterol-lowering medication) or total
cholesterol ≥200 mg/dl or HDL-C <40 mg/dl
Hypertension: history of known and treated
Yusufali et al.
hypertension (receiving antihypertensive medication) or
(2015) [42]
SBP ≥140 mm Hg or DBP ≥90 mm Hg Obesity: BMI
≥30.0 kg/m2 Diabetes: history of known and treated
diabetes (receiving antihyperglycemic medication) or
HbA1c ≥6.5% Central obesity: WC ≥102 cm in male and
≥88 cm in female
Diabetes: FBG >125 mg/dL, use of diabetes medications,
or self-reported diabetes (ADA) Prehypertension: BP
≥120/80 mm Hg on more than 2 occasions
Baynouna et al.
Hypertension: BP>140/90 mm Hg on both visits (JNC
(2008) [43]
criteria) Obesity: BMI ≥30 kg/m2 Metabolic syndrome:
≥3 of the following: central obesity, high TG, low HDLC, high BP, or IFG (ATP III criteria) Central obesity (not
deﬁned) Dyslipidemia (not deﬁned)
Overweight (not deﬁned) Obesity (not deﬁned) Central
obesity: elevated WC with ethnicity-speciﬁc values
Hajat and
Prediabetes: HbA1c 5.7%–6.4% (ADA classiﬁcation)
Harrison (2010)
Diabetes: HbA1c ≥6.5% or random glucose
[44]
>11.1 mmol/L or self-reported history of diabetes
warranting treatment Framingham Risk Score
Overweight: BMI 25 to 29.9 kg/m2 Obesity: BMI
≥30 kg/m2 Central obesity: WHR ≥0.85 for women and
≥0.9 for men Hypertension: self-reported past history of
Hajat et al. (2012) high BP requiring medication or a single elevated clinical
BP reading (SBP ≥140 mmHg or DBP ≥90 mmHg)
[20]
Dyslipidemia: self-reported past history of abnormal
cholesterol levels requiring medication or a measured
LDL-C ≥4.1 mmol/L or HDL-C ≤1.0 mmol/L
Emirate: Abu Dhabi Nationality: Emirati Mean
age: 35.2 (13.8)

Emirate: Abu Dhabi Nationality: Emirati
Gender: female: 57%; male: 43% Mean age: 36.82
(14.3)

Cross-sectional
Period: April
2008–April 2010

Cross-sectional
Period: April
2009–June 2010

Cross-sectional
Period: February
2004–February 2005

Emirate: Dubai, Abu Dhabi, Sharjah, Fujairah,
Opportunistic sampling
and Ras Al Khaimah Nationality: Emirati: 6.7%;
(convenient recruitment from
other Arabs: 9.9%; South Asians: 73.7%; other shopping malls, outpatient health
Asians: 4.6%; others: 5.1% Mean age: 38 (11)
care facilities, and labor camps)
Gender: male: 75%; female: 25%
Sample #: 4,128

Cross-sectional
Period: SeptemberOctober 2012

All individuals included in the
WEQAYA screening program
Sample #: 50,138

All individuals included in the
WEQAYA screening program
Sample #: 173,501

Two-stage sampling: stage 1:
selection of PHCs stratiﬁed by
geography (choose the busiest if
Emirate: Abu Dhabi Nationality: Emirati
more than 1); stage 2: random
Gender: female: 51.8%; male: 48.2% Mean age:
selection from lists of possession of
44.1 (range: 25–68)
a health card, stratiﬁed by gender
(randomization method not
detailed) Sample #: 817

Emirate: All (national) Nationality: Emirati:
40%; others: 60% Gender: male: 43%; female:
57% Age: ≥20 years

Participants recruited from the
2000 Emirates National Diabetes
study and screening for risk factors
for Coronary Artery Disease Study
Multistage, stratiﬁed, cluster
random sampling (not detailed)
Sample #: 5,844

Two-stage sample: stage 1: houses
(simple random sample of houses
listed in the electricity department);
stage 2: all men and nonpregnant
women living in chosen houses
Sample #: 452 houses (2455 adults,
including 2396 for whom diabetes
status was available)

Sampling

Cross-sectional
Period: 1999-2000

Prediabetes: impaired fasting glucose (venous blood
glucose: 5.6–6.9 mmol/L) or impaired glucose tolerance
(2 h post-OGTT venous blood glucose:
Cross-sectional
Emirate: Abu Dhabi (Al Ain) Nationality:
Saadi et al. (2007)
7.8–11.0 mmol/L) Diabetes: fasting venous blood
Period: December
Emirati Gender: female: 50.9%; male: 49.1% Age:
[41]
glucose concentration ≥7.0 mmol/L and/or 2 h post- 2005–November 2006
≥18 years
OGTT venous blood glucose concentration
≥11.1 mmol/L (WHO expert group)

Author
and year

Table 1: Continued.
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Diabetes: FBG ≥126 mg/dL or previous ﬁrst diagnosis of
Retrospective cohort
diabetes or documented diabetes by a physician
Period: January
Impaired fasting glucose: FBG 110–126 mg/dL or
2010–December 2010
documented impaired fasting glucose by a physician

Sreedharan et al.
(2015) [13]

Cross-sectional
Period: 2005/2008

Obesity: ≥30 kg/m Diabetes (not deﬁned) Hypertension
(not deﬁned)

Newson-Smith
(2010) [46]

2

Cross-sectional
Period: May
1995–January 1996

Study type

Emirati and non-Emirati in Ajman

Nationality: Emirati: 13.3%; Indians: 43.1%;
Egyptians: 15.1%; Filipinos: 7.3%; others: 21.2%
Gender: male Mean age: 37.3 (range: 19–64
years) Other characteristics: oil and gas
company workers

Emirate: Abu Dhabi Gender: male Age range:
35–49 years Other characteristics: oﬃce based in
a group of petroleum companies

Participant characteristics

Exhaustive (all cases treated in 5
PHCs and 2 general hospitals
where most of the diabetic patients
are presumed to be managed)
Sample #: NR

Unclear Sample #: 1,037

Convenient sampling Sample #:
358

Sampling

BMI: body mass index; NHANES: National Health and Nutrition Examination Survey; PPS: probability proportional to size; IOTF: International Obesity Task Force; SD: standard deviation; WHO: World Health
Organization; CDC: Centers for Disease Control and Prevention; NR: not reported; UAE: United Arab Emirates; NHLBI: National Heart, Lung, and Blood Institute; IDF: International Diabetes Federation; WC:
waist circumference; HDL-C: high-density lipoprotein cholesterol; FBG: fasting blood glucose; BP: blood pressure; TG: triglycerides; SBP: systolic blood pressure; DBP: diastolic blood pressure; AHA: American
Heart Association; NCEP: National Cholesterol Education Program; WHR: waist-to-hip ratio; JNC: Joint National Committee; OGTT: oral glucose tolerance test; HbA1c: hemoglobin A1c; ADA: American
Diabetes Association; ATP: Adult Treatment Panel; LDL-C: low-density lipoprotein cholesterol; BG: blood glucose; PHC: primary health care center.

Incidence

Employees

Studied disease (criteria)

IGT: FBG <7.8 mmol/L and 2-hour BG:
7.8–11.1 mmol/L Diabetes: FBG >7.8 mmol/L or 2-hour
Hossain and Malik
BG >11.1 mmol/L Elevated blood cholesterol: fasting
(1998) [45]
total cholesterol >200 mg/dl Obesity: BMI ≥24.99 kg/m2
and WHR >1.0

Author
and year

Table 1: Continued.
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Obesity in
children

Overweight: girls: 13.1%; boys: 18.5%
Obesity: girls: 20.5%; boys: 22.2%

Overweight: 14.7% (boys: 11.7%; girls: 17.6%)
Obesity: 18.9% (boys: 20.7%; girls: 17.0%)
Emirati nationals:
Overweight: 14.2% (boys: 11.6%; girls: 16.7%)
Obesity: 19.8% (boys: 21.4%; girls: 18.1%)

Al Junaibi et al.
(2013) [25]

Under 5 years:
Overweight: boys: 13.45%; girls: 12.98%
Obesity: boys: 6.06%; girls: 6.54%
At age 13–17:
Overweight: boys: 14.16%; girls: 15.16%
Obesity: boys: 6.08%; girls: 9.94%
At age 18:
Overweight: boys: 25%; girls: 30%
Obesity: boys: 7%; girls: 10%
Overweight: 9.0% (boys: 8.5%; girls: 9.3%)
Obesity: 7.9% (boys: 7.9%; girls: 7.9%)
Emirati:
Overweight: CDC: 17%; IOTF: 16%; WHO: 4.5%
Obesity: CDC: 20%; IOTF: 14%; WHO: 30.3%
Residents:
Overweight: CDC: 14% (calculated ﬁgure)
Obesity: CDC: 18% (calculated ﬁgure)

Overweight: girls: 19.8%, 95% CI: 18.3–21.6; boys: 19.2%, 95% CI: 17.6–20.9
Obesity: girls: 12.4%, 95% CI: 11.1–13.8; boys: 13.1%, 95% CI: 11.6–14.5
Emirati:
Overweight: girls: 17.6%, 95% CI: 15–20.2; boys: 17.3%, 95% CI: 15.3–19.9
Obesity: girls: 14.3%, 95% CI: 11.5–16.7; boys: 12.7%, 95% CI: 10.4–14.6
Others:
Overweight: girls: 25%, 95% CI: 22.8–27.5; boys: 20.5%, 95% CI: 18.6–22.5
Obesity: girls: 13.5%, 95% CI: 11.8–15.4; boys: 14.6%, 95% CI: 12.5–16.7

Prevalence of cardiometabolic disease(s)
At risk for overweight: 14%
Overweight: 9% (at risk for overweight and obesity: Abu Dhabi: 21%; Sharjah: 24%;
Dubai: 27%; Ras Al Khaimah: 22%; Fujairah: 30%)
Overweight: 18.6% (calculated) (boys: 17.1%; girls: 20.1%)
Obesity: 7.4% (calculated) (boys: 7.7%; girls: 7.1%)

Bin Zaal et al.
(2009) [24]

Al Blooshi et al.
(2016) [23]

Al-Haddad et al.
(2000) [14]

Abdulrazzaq et al.
(2011) [16]

Malik and Bakir
(2007) [15]

Al-Haddad et al.
(2005) [22]

Al Hourani et al.
(2003) [21]

Author and year

Protective factors:
Girls: always eating breakfast (OR � 0.5; 95% CI 0.2–1.0); eating breakfast at school
(OR � 3.4; 95% CI 1.6–7.4); frequently snacking in between breakfast and lunch
(OR � 0.5; 95% CI 0.3–0.9); meat consumption ≥4 times/week (OR � 0.1; 95% CI
0.02–1.0); chocolates and sweets consumption ≥4 times/week (OR � 0.5; 95% CI
0.3–0.8); soft drinks consumption ≥4 times/week (OR � 0.5; 95% CI 0.3–0.8); fast
foods consumption ≥4 times/week (OR � 0.5; 95% CI 0.3–0.8)
Boys: fruit consumption: ≥4 times/week (OR � 0.6; 95% CI 0.4–1.0)
Predictors:
Boys: eating breakfast at school (OR � 3.0; 95% CI 1.1–8.3)
Positive correlation between child’s BMI percentiles and parental BMI (for every
kg/m2 of parental BMI, the child’s BMI percentile increased by 2.34 percentile
points)
Negative correlation between child’s BMI percentiles and dairy consumption (each
additional daily dairy consumption was associated with a reduction in BMI by 2.52
percentile points; p < 0.001)

Age and gender: prevalence of overweight, obesity, and extreme obesity increased
linearly with age in children 3–12 y (3.89% per year, R2 ≥ 0.962); a rate 28% higher in
boys than in girls

Not assessed

Not assessed

Obesity:
Predictors:
Non-Emirati boys (OR � 1.783, CI 1.499–2.121)
Non-Emirati girls (OR � 1.767, CI 1.48–2.102)
Birth outside the UAE (OR � 1.173, CI 1.015–1.306)
Girls living in rural areas (OR � 1.614, CI 1.348–2.001)
Protective factors:
Boys living in rural areas (OR � 0.732, CI 0.591–0.912)
Overweight:
Protective factors:
Non-Emirati boys (OR � 0.662, CI 0.572–0.769)
Non-Emirati girls (OR � 0.569, CI 0.461–0.703)
Boys living in rural areas (OR � 0.785, CI 0.629–0.974)

Not assessed

Not assessed

Risk factors (multivariate analysis)

Table 2: Epidemiology of cardiometabolic diseases in the United Arab Emirates and risk of bias in the included studies.
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Metabolic
syndrome

Obesity in
community

Obesity in
university
students

Malik and Razig
(2008) [17]

Al Dhaheri et al.
(2016) [36]

Mehairi et al.
(2013) [35]

Carter et al. (2004)
[34]

Ng et al. (2011) [3]

Musaiger and
Radwan (1995)
[32]
Papandreou et al.
(2015) [33]

Kerkadi (2003)
[31]

Al Mukhtar (2000)
[19]
Badr and ElSabban (2008)
[28]
Musaiger et al.
(2003) [29]
Sheikh-Ismail
et al. (2009) [30]

Amine and Samy
(1996) [27]

Musaiger et al.
(2012) [26]

Author and year

Overweight (aOR � 3.8, 95% CI: 1.15–12.52)
Obesity (aOR � 11.2, 95% CI: 3.1–40.9)
WHR >0.8 (aOR � 3.04, 95% CI: 1.10–8.44)
HbA1c 5.6–6.4% (aOR � 8.92; 95% CI: 3.39–23.48)
HbA1c>6.5% (aOR � 22.5, 95% CI: 6.37–79.42)
Predictors of metabolic syndrome for both deﬁnitions:
Increasing age (≥40 years), female gender, and family history of diabetes

Predictors of metabolic syndrome:
Boys: screen time (aOR: 1.08, 95% CI: 1–1.17); BMI (aOR: 1.26, 95% CI: 1.2–1.33)
Girls: BMI (aOR: 1.22, 95% CI: 1.2–1.33)

Age (OR � 1.05; 95% CI 1.04–1.07)

Not assessed

Not assessed

Overweight and obesity: 28.4%

Adult female: overweight: 31.4%; obesity: 34.2%; elevated WC: 53.2%
Adolescent female: overweight: 20.5%; obesity: 19.7%
Adolescent male: overweight: 16.2%; obesity: 11.7%
Children (girls): overweight: 23.6%; obesity: 17.1%
Children (boys): overweight: 9.1%; obesity: 15.9%
Overweight: 27%
Obesity: 35%
Metabolic syndrome: 13% (boys: 22%; girls: 4%)
Elevated WC: boys: 22%; girls: 4%
IFG: boys: 13%; girls: 6%
Low HDL: boys: 88%; girls: 74%
Elevated TG: boys: 5%; girls: 1%
Hypertension: boys: 5%; girls: 8%
Overweight or obesity: 34.6% (boys: 39%; girls: 30%)
Metabolic syndrome: 6.8% (95% CI: 5–9%)
(reduced HDL-C: 48.8%; elevated WC: 18.2%; elevated FBG: 9.7%; elevated BP:
5.4%; hypertriglyceridemia: 1.4%)
(At least 1 component: 38.4%; 2 components: 11.2%; 3 components: 4.9%; 4
components: 1.8%; 5 components: 0.2%)
Metabolic syndrome:
NCEP deﬁnition: 38.4% (36.9–39.9) (male: 32.4% (30–34.3); female: 47.0%

No statistical signiﬁcance was found for any of the assessed risk factors

Signiﬁcant association in bivariate analysis between obesity and higher
consumption of cereals and fruits (p < 0.005)

Not assessed

Predictors:
Family history of obesity (RR � 1.88); not practicing sport (RR � 1.77)

Positive correlation between BMI of males and their fathers’ BMI (r � 0.51;
p < 0.0001)

Not assessed

Signiﬁcant association (bivariate analysis) between obesity and:
Obesity during childhood
Obesity among parents (both or mother or father only)
Eating between meals (regularly or occasionally)

Not assessed

Risk factors (multivariate analysis)

Overweight: 19%
Obesity: 9.8%

Overweight: 27% (age group: 20–<30: 21%; 30–<60: 33%; >60: 15%)
Obesity: 16% (age group: 20–<30: 8%; 30–<60: 24%; >60: 14%)
Obesity: 6.7%
Overweight: 19.4%
Reported hypertension: 2.8%
Reported diabetes: 1.4%

Obesity: 35.7%

Prevalence of cardiometabolic disease(s)
IOTF:
Overweight: 15.24% (boys: 16.8%; girls: 13.6%)
Obesity: 13.07% (boys: 19.1%; girls: 6.6%)
CDC:
Overweight: boys: 11.1%; girls: 11.5%
Obesity: boys: 22.5%; girls: 7%
Overweight: 10.8%; obesity: 30.6%
Abu Dhabi: overweight: 12.3%; obesity: 31.6%
Dubai: overweight: 4%; obesity: 31.3%
Sharjah: overweight: 10.1%; obesity: 28.4%
Ras Al Khaimah: overweight: 15.2%; obesity: 29.1%
Others: overweight: 11.8%; obesity: 31.4%
Overweight: 24.0% (<20 years: 27.3%; ≥20 years: 21.9%)
Obese: 7.5% (<20 years: 6.5%; ≥20 years: 8.2%)
Overweight and obesity: 13.3%
Female: overweight and obesity: 8.1%
Male: overweight and obesity: 22.2%

Table 2: Continued.
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Diabetes

Hypertension

Dyslipidemia

El-Shahat et al.
(1999) [39]

Predictors of higher FBG:
(Age-adjusted prevalence)
Age 40–59: B � 1.59, SE � 0.4; ≥60 y: B � 1.01, SE � 0.43; tribe (Shamsi): B � 2.07, SE
Diabetes: 6% (male: 5.8%; female: 6.1%; Shamsi: 18.7%; others: 4.2%; rural: 4.0%;
� 0.60; residence (urban): B � 1.56, SE � 0.37
urban: 9.2%)
Predictors of higher BMI:
Obesity: male: 10.7%; female: 27.4%; Shamsi: 16.1%; others: 21.8%; rural: 17.9%; Age 40–59: B � 1.85, SE � 0.62; gender (female): B � 1.93, SE � 0.54; tribe (Shamsi):
El Mugamer et al.
urban: 26.7%
B � −2.18, SE � 0.94; residence (urban): B � 1.82, SE � 0.59
(1995) [40]
Elevated SBP: male: 23.0%; female: 19.7%; Shamsi: 12.9%; others: 22.2%; rural:
Predictors of higher SBP:
19.2%; urban: 24.9%
Age 40–59: B � 11.5, SE � 2.7; ≥60 y: B � 21.2, SE � 2.9
Elevated DBP: male: 17.9%; female: 12.8%; Shamsi: 16.1%; others: 14.7%; rural:
Predictors of higher DBP:
12.1%; urban: 18.3%
Age 40–59: B � 7.9, SE � 1.5; ≥60 y: B � 6.5, SE � 1.7; gender (female): B � −3.0, SE �
1.3

Not assessed

Hypertension: 36.6% (calculated according to census in Sharjah: 31.6%)
Stage I: 32%; stage II: 4%; stage III: 0.05%
Female: 33.7% (stage I: 28.3%; stage II: 4.8%; stage III: 0.05%)
Male: 40.3% (stage I: 36.7%; stage II: 2.9%; stage III: 0.6%)

Abdulle et al.
(2014) [38]

Not assessed

Risk factors (multivariate analysis)

Predictors of systolic BP Z-scores:
Age (B(SE) � –0.010 (0.005)); BMI CDC percentile (B(SE) � 0.006 (0.001))
Predictors of diastolic BP Z-scores:
BMI CDC percentile (B(SE) � 0.002 (0.0003)); sex (B(SE) � –0.113 (0.025))
Positive relationship between BP Z-scores and weight status in all age groups and
both sexes

Prevalence of cardiometabolic disease(s)
(44.6–49.3))
IDF deﬁnition: 40.5% (39–42) (male: 32.9% (30.7–35.2); female: 45.9% (43.9–47.9))
Abdominal obesity:
NCEP deﬁnition: 44.8% (43.3–46.3) (male: 25.3% (23.3–27.4); female: 60% (58–62))
IDF deﬁnition: 69.9% (68.5–71.3) (male: 63.4% (61.1–65.7); female: 74.6%
(72.7–76.2))
High BP: 38.4% (36.9–39.9) (male: 47% (44.6–49.3); female: 32.4% (30–34.3))
High fasting plasma glucose: 50.7% (male: 46.4% (44.1–48.8); female: 53.7%
(51.7–55.6))
High plasma TG: 33.5% (32.1–34.9) (male: 43.6% (41.2–46); female: 26.4%
(24.7–28.2))
Low HDL-C: 53.9% (52.3–55.4) (male: 43.4% (41.1–45.8); female: 61.2%
(59.3–63.1))
Emirati:
Metabolic syndrome:
NCEP deﬁnition: 42.9% (40.1–44.8) (male: 31% (27.1–38.9); female: 51.2%
(48.1–54.1))
IDF deﬁnition: 41.8% (39.5–44.1) (male: 37.1% (33–41.5); female: 44.3%
(41.5–47.1))
Dyslipidemia (total cholesterol)
UAE nationals: borderline: 33.3%; high: 19.8%
Arabs (non-UAE): borderline: 29.5%; high: 19.6%
Non-Arabs: borderline: 31%; high: 11.4%
Female: borderline: 34.2%; high: 15.1%
Male: borderline: 29.9%; high: 18.1%
<51 years: borderline: 36.3%; high: 16.5%
>51 years: borderline: 34.7%; high: 22.6%
Prehypertension: 10.9% (male: 10.5%; female: 11.4%)
Hypertension: 16.5% (male: 15.4%; female: 17.8%)
Systolic hypertension: 14.6% (male: 14.4%; female: 14.8%)
Diastolic hypertension: 4.9% (male: 2.5%; female: 7.4%)

Agarwal et al.
(1995) [37]

Author and year
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factors

Prevalence of cardiometabolic disease(s)
Risk factors (multivariate analysis)
Reported:
Diabetes: 10.2% (male: 9.4%; female: 11.1%)
Segi-standardized rates among 30- to 64-year-olds: 20.6% (male: 17.7%; female:
22.1%)
Measured:
Diabetes: 25.9% (diagnosed: 15.3%; undiagnosed: 10.7%); male: 27.1% (diagnosed:
Saadi et al. (2007) 18.9%; undiagnosed: 8.2%); female: 25.5% (diagnosed: 13.5%; undiagnosed: 12.0%)
Predictors of undiagnosed diabetes:
[41]
Prediabetes: 22.8% (male: 19.7%; female: 24.3%)
BMI: B � 0.088; age: B � 0.059
Adjusted for the probability of inclusion in the study:
Diabetes: 17.1% (diagnosed: 10.5%; undiagnosed: 6.6%)
Prediabetes: 20.2%
Age-standardized rates among 30- to 64-year-olds:
Diabetes: 29.0% (diagnosed: 15.0%; undiagnosed: 14.0%)
Prediabetes: 24.2%
Diabetes:
Crude: 20.2% (male: 21.5% (including newly diagnosed: 35.6%); female: 19.2%
(including newly diagnosed: 44.9%))
Age-standardized rates (95% CI): 21.4% (20.4–22.4) (male: 20.4% (18.8–22); female:
22.3% (20.9–23.7))
Predictors of diabetes:
IFG:
WHR: OR � 1.73, 95% CI: 1.18–2.55; age: OR � 1.06, 95% CI: 1.05–1.07; SBP: OR �
Crude: 6.5% (male: 4.5%; female: 8%)
Malik et al. (2005)
1.01, 95% CI: 1.001–1.01; BMI: OR � 1.04, 95% CI: 1.02–1.05
Age-standardized rates (95% CI): 6.6% (6–7.2) (male: 4.5% (3.7–5.3); female: 7.2%
[18]
Protective factors for diabetes:
(6.3–8.1))
Nationality: Shwam: OR � 0.45, 95% CI: 0.36–0.57; Egypt/North Africa: OR � 0.7,
Overweight: crude: 40%
95% CI: 0.55–0.9; Sudan/East Africa: OR � 0.6, 95% CI: 0.45–0.8
Obesity: crude: 33%
Emirati:
Diabetes: crude: 24.5%; age-adjusted rate: 25.1%
IFG: crude: 8.8%; age-adjusted rate: 8.5%
Obesity: crude: 37%
Mean 10-year Framingham CVD Risk Score: 5.3 (7.1) (male: 5.5 (7.3); female: 4.7
(6.0)) (Emirati: 7.2)
Diabetes: 31.6% (Emirati: 46.2%; other Arabs: 29.3%; South Asians: 31.7%; other
Asians: 22.1%; others: 23.2%)
Hypertension: 30.6% (Emirati: 30.2%; other Arabs: 22.9%; South Asians: 31.5%;
other Asians: 39%; others: 24.2%)
Predictors of risk factors:
Yusufali et al.
Dyslipidemia: 68.5% (Emirati: 666.2%; other Arabs: 69.3%; South Asians: 71%;
Male gender (OR: 3.441; 95% CI: 2.930 to 4.042)
(2015) [42]
other Asians: 53.2%; others: 47.9%)
Protective factor:
Overweight: 41.9% (Emirati: 34.3%; other Arabs: 41.9%; South Asians: 43.1%; other
Age (per 10 years) (OR: 0.834; 95% CI: 0.784 to 0.886)
Asians: 40.4%; others: 35.8%)
Obesity: 19.6% (Emirati: 46.6%; other Arabs: 40.9%; South Asians: 14.1%; other
Asians: 16%; others: 25.5%)
Central obesity: 24% (Emirati: 55.8%; other Arabs: 43.5%; South Asians: 18.5%;
other Asians: 27.9%; others: 33%)
Diabetes: 23.3% (self-reported: 19.5%; additionally measured: 3.8%) (female: 18.4%;
male: 10.4%)
Prehypertension: 7.3%
Baynouna et al.
Hypertension: 20.8% (self-reported: 20%; additionally measured: 0.8%) (female:
Not assessed
(2008) [43]
19.8%; male: 21.8%);
Obesity: 37.3% (female: 46.5%; male: 28.3%)
Central obesity: 39% (female: 59.9%; male: 37.2%)

Author and year

Table 2: Continued.
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Sreedharan et al.
(2015) [13]

Newson-Smith
(2010) [46]

Preemployment assessment:
Obesity: 16.6% (Emiratis: 31.9%; Pakistanis: 16.6%; Filipinos: 5.9%; Indians: 2.4%)
Diabetes: 2.5% (Emiratis: 3.6%; Pakistanis: 0%; Filipinos: 2.9%; Indians: 1.6%)
Hypertension: 15.5% (Emiratis: 0%; Pakistanis: 16%; Filipinos: 32.4%; Indians:
28.4%)
Not assessed
At periodic health evaluation:
Obesity: 8.6% (Emiratis: 29%; Pakistanis: 43%; Filipinos: 8%; Indians: 7%)
Diabetes: 11.3% (Emiratis: 0%; Pakistanis: 21.4%; Filipinos: 9.5%; Indians: 11.6%)
Hypertension: 37% (Emiratis: 12.5%; Pakistanis: 50%; Filipinos: 47.6%; Indians:
37.3%)
Overall incidence in ≥20 years: 4.8/1,000 PY
Gender-speciﬁc incidence rate: male: 3.3/1,000 PY; female: 6.3/1,000 PY
ASR in male and female was almost similar until the age of 39 years; then, females
Highest incidence rate for both genders: age group: 55–59 (male: 23.4/1,000 PY;
≥40 years showed a higher incidence rate than males
female: 32.4/1,000 PY)

IGT: 18%
Diabetes: 10%
Obesity (deﬁned by BMI): 68%, and obesity (deﬁned by WHR): 31%
Elevated blood cholesterol: 74%

Predictors of obesity (elevated BMI):
Peninsular Arab: aOR: 3.06 (1.44–6.54); Shwam: aOR: 4.14 (1.96–8.75); Egyptian:
aOR: 4.64 (1.4–15.21); WHR >1: aOR: 3.31 (1.77–6.18)
Predictor of obesity (elevated WHR):
BMI >25: aOR: 3.57 (1.89–6.73)
Predictor of elevated total cholesterol:
age 45–49: aOR: 2.8 (1.47–5.32)
Protective factors of abnormal glucose tolerance:
Shwam: aOR: 0.37 (0.17–0.78); Egyptian: aOR: 0.31 (0.1–0.96)
Protective factors of obesity (elevated WHR):
Afro-Arab: aOR: 0.14 (0.03–0.64); European: aOR: 0.15 (0.03–0.72); medium
physical activity: aOR: 0.4 (0.19–0.83); heavy physical activity: aOR: 0.27 (0.09–0.8)

Not assessed

Not assessed

Risk factors (multivariate analysis)

CI: conﬁdence interval; OR: odds ratio; UAE: United Arab Emirates; CDC: Centers for Disease Control and Prevention; IOTF: International Obesity Task Force; WHO: World Health Organization; BMI: body
mass index; aOR: adjusted odds ratio; HDL-C: high-density lipoprotein cholesterol; WC: waist circumference; FBG: fasting blood glucose; BP: blood pressure; HbA1c: Hemoglobin A1c; NCEP: National
Cholesterol Education Program; IDF: International Diabetes Federation; TG: triglycerides; SE: standard error; IFG: impaired fasting glucose; WHR: waist-to-hip ratio; CVD: cardiovascular disease; ASR: agestandardized rate; IGT: impaired glucose tolerance; PY: person-years.

Incidence

Workers

Hossain and Malik
(1998) [45]

Prevalence of cardiometabolic disease(s)
Metabolic syndrome: 22.7% (female: 24.2%; male: 21.3%)
Dyslipidemia: 58.9% (female: 53.9%; male: 64%)
Overweight: 32%
Obesity: 35%
Hajat and
Central obesity: 57%
Harrison (2010)
Either prediabetes or diabetes: 44%
[44]
Framingham CVD Risk Score:
>10%: male: 20.32%; female: 9.51%; overall: 14.22%
>20%: male: 7.59%; female: 2.56%; overall: 4.75%
Obesity: crude: 35.4% (female: 38.3%; male: 31.6%); ASR: 41.1% (40.7; 41.5)
Morbid obesity: 5% (female: 6%; male: 4%)
Overweight: crude: 31.9% (female: 28.8%; male: 36.1%); ASR: 34% (33.6; 34.4)
Central obesity: crude: 54.8% (female: 51.9%; male: 58.6%); ASR: 62.4% (61.9; 62.8)
Hajat et al. (2012)
Dyslipidemia: crude: 44.2% (female: 33.9%; male: 57.7%); ASR: 50.7% (50.3; 51.2)
[20]
Hypertension: crude: 23.1% (female: 20.9%; male: 26%); ASR: 29.2% (28.8; 29.6)
Prediabetes: crude: 27.1% (female: 26.5%; male: 27.8%); ASR: 29.5% (29.1; 29.9)
Diabetes: crude: 17.6% (female: 17.9%; male: 17.4%); ASR: 24.6% (24.2; 25) (newly
diagnosed: 35%; self-reported history: 65%)

Author and year

Table 2: Continued.
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Agarwal et al.
(1995) [37]
Al-Dhaheri
et al. (2016)
[36]
Al Junaibi
et al. (2013)
[25]
Al-Mukhtar
et al. (2000)
[19]
Badr and ElSabban
(2008) [28]
Hossain and
Malik (1998)
[45]
Kerkadi
(2003) [31]
Musaiger
and Radwan
(1995) [32]
Musaiger
et al. (2003)
[29]
Papandreou
et al. (2015)
[33]
Yusufali et al.
(2015) [42]
Abdulle et al.
(2014) [38]
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Abdulrazzaq
et al. (2011)
[16]
Al Blooshi
et al. (2016)
[23]
Al-Haddad
et al. (2000)
[14]
Al-Haddad
et al. (2005)
[22]
Al-Hourani
et al. (2003)
[21]
El-Shahat
et al. (1999)
[39]
Amine and
Samy (1996)
[27]
Baynouna
et al. (2008)
[43]
Bin Zaal et al.
(2009) [24]
Carter et al.
(2004) [34]
El Mugamer
et al. (1995)
[40]

Author and
year
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Items were categorized as having a “high risk,” “intermediate risk,” or “low risk” of bias. Unclear or poor reporting was considered as a high risk of bias. Studies were regarded as having a high overall risk of bias if
they meet less than 5 criteria, moderate risk if they meet 5 to 7 criteria, and low risk if they meet 8 or more of the 10 items.

Hajat and
Harrison
(2010) [44]
Hajat et al.
(2012) [20]
Malik et al.
(2005) [18]
Malik and
Bakir (2007)
[15]
Malik and
Razig (2008)
[17]
Mehairi et al.
(2013) [35]
Musaiger
et al. (2012)
[26]
NewsonSmith (2010)
[46]
Ng et al.
(2011) [3]
Saadi et al.
(2007) [41]
SheikhIsmail et al.
(2009) [30]
Sreedharan
et al. (2015)
[13]

Author and
year

Was the
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Was the
population
sampling
a close
frame a true or
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close
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representation
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of the target
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sex-speciﬁc rates, highlighting a greater proportion of
overweight and obesity in boys compared to girls in Abu
Dhabi. In contrast, Dubai shows almost equal rates of obesity
in the two sexes (girls 21% and boys 22%), yet higher rates of
overweight in boys (19%) compared to girls (13%) [24].
Conversely, Sharjah shows identical overweight rates among
its boys and girls (11%), with more than triple the rate of
obesity in its boys (23%) compared to girls (7%) [26].
4.1.2. University Students. All studies addressing the rates of
cardiometabolic disorders among university students were
conducted at the UAE University in Al Ain, Abu Dhabi.
They report varying rates of overweight and obesity across
female university students, ranging between 29% [32] and
46% [30]. In contrast, only one study tackled male university
students and reported an obesity rate of 35% among them
[29] without reporting their overweight rates.
4.1.3. Adults. A study conducted at the national level between 1999 and 2000 reported prevalence rates of 40% and
30% for overweight and obesity, respectively, in Emirati and
non-Emirati adults combined [14]. In contrast, a more recent study reports a prevalence of 42% for overweight and
20% for obesity in 2012 among the same abovementioned
population [42]. However, the latter study recruited a convenient sample of Emirati and non-Emirati adults in 5 of the
UAE’s 7 emirates, making the deduction of temporal trends
somewhat unreliable. Regarding sex-speciﬁc rates in the
adult population, a recent national study shows that nearly
two-thirds of adult Emirati females carry excess body weight
(31% overweight and 34% obese) [3], yet it does not report
any estimates for males. However, an earlier study found
remarkable diﬀerences in sex-speciﬁc rates of obesity,
reporting a prevalence of 47% in women compared to 28% in
men [43]. The same study reported an overall estimate of
37% for overweight and obesity in Emirati adults residing in
Abu Dhabi [43]. Likewise, in a study reporting emiratespeciﬁc rates, it was estimated that around three-quarters of
the Emirati adults residing in Abu Dhabi carry excess body
weight, with 34% and 41% of them being overweight and
obese, respectively [20].
4.2. Metabolic Syndrome. The national estimates of metabolic syndrome among Emirati and non-Emirati adults were
38% and 41%, respectively, in 1999-2000, using the National
Cholesterol Education Adult Panel III (NCEP) and IDF
deﬁnitions [17]. Interestingly, regardless of the deﬁnition
used, the rate of metabolic syndrome appears to be higher in
females compared to males (47% and 46% versus 32% and
33%, according to the NCEP and IDF deﬁnitions, respectively). Particularly, the two components that were more
accentuated in females compared to males in the NCEP
deﬁnition were a low level of high-density lipoprotein
cholesterol (HDL-C) (54% of cases) and a high fasting
plasma glucose (51% of cases) [17]. As for schoolchildren in
Abu Dhabi, around 13% of those aged 12 to 18 years suﬀer
from metabolic syndrome as deﬁned by the IDF, although

17
with a greater prevalence in boys (22%) than girls (4%) [35].
According to that study, the most common components of
the IDF deﬁnition that remarkably diﬀered between the two
sexes were a low HDL-C and an elevated waist circumference. Finally, among university students, only 7% of the
female Emirati students attending the UAE University were
found to have metabolic syndrome [36], with 38% of the
study’s participants satisfying at least one component of the
IDF deﬁnition of metabolic syndrome [36].
4.3. Dyslipidemia. One study particularly addressing dyslipidemia, deﬁned as a total cholesterol >240 mg/dL, reports
prevalence estimates of 19% in Emirati and non-Emirati
Arabs compared to 11% in non-Arabs [29]. The study also
shows increasing rates with advancing age (23% in those > 51
years old versus 17% in younger participants). A more recent
study addressing dyslipidemia estimates in a convenient
sample of adults from 5 emirates (Dubai, Abu Dhabi, Sharjah,
Fujairah, and Ras Al Khaimah) reports a 69% overall rate of
elevated total cholesterol (≥200 mg/dl) or reduced HDL-C
level (<40 mg/dl) [42]. The study was conducted as part of
assessing the cardiometabolic status of those emirates [42].
Two other studies conducted 5 years apart (2004-2005 [43]
and 2009-2010 [20]) report comparable rates of dyslipidemia
among the Emirati citizens of Abu Dhabi (59% and 51%,
respectively), despite using diﬀerent disease deﬁnitions. Interestingly, Hajat et al. highlight sex-based diﬀerences in the
rates of dyslipidemia (deﬁned as LDL-C ≥ 4.1 mmol/L or
HDL-C ≤ 1.0 mmol/L), reporting a prevalence of 57.7% in
men compared to 33.9% in women [20].
4.4. Impaired Fasting Glucose, Prediabetes, and Diabetes.
The sole study conducted at the national level in the UAE
was between 1999 and 2000, reporting a prevalence of 21%
for diabetes and 7% for impaired fasting glucose (IFG) [18].
A decade later, another study addressing the prevalence of
diabetes in a convenient sample from ﬁve emirates reported
an increase in prevalence to 32% [42]. However, Abu Dhabi
remains the only emirate in which diabetes prevalence can
be trended, given the multiple studies on the topic since 1989
[20, 40, 41, 43]. Of these studies, the oldest reports an agestandardized rate (ASR) of 6% for diabetes within a purposive sample of Bedouin Emirati adults between 1989 and
1990 [40]. The subsequent study, conducted more than
a decade later, reports an increase in the ASR of diabetes to
17%, with a concomitantly high ASR for prediabetes (20%)
[41]. Another study conducted afterward reports an even
higher estimate for diabetes (23%) [43]. Finally, the most
recent of those studies states that more than half of the
Emirati adults of Abu Dhabi suﬀer from dysglycemia,
reporting increased estimates of both diabetes (24.6%) and
prediabetes (29.5%), with no signiﬁcant diﬀerences across
the corresponding sex-speciﬁc rates [20]. Thus, by comparing the diabetes estimates reported in those studies in
their respective chronological order, we clearly recognize an
uptrend in the prevalence of diabetes in Abu Dhabi
throughout the years. On the contrary, only one study
addresses the incidence of diabetes in Ajman, reporting an
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Table 4: Cost of illness for diabetes from Al-Maskari et al. [12].

Economic burden
Time
(annual
Major limitations
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adjusted to 2015)
Microvascular
complications:
Components:
US$3,453 ($4,334
direct costs (visits
adjusted to 2015)
Cost data: oﬃcial to primary health
Macrovascular
care centers or
list of charges/rates
Self-reported
complications:
diabetes clinic,
for patients not
150 (recruited from
questionnaire,
US$10,300
laboratory tests,
covered by health
2 outpatient clinics
($12,929 adjusted uncertainties not
medications,
insurance
Health
Crossat Al Ain, Abu
thoroughly
to 2015)
hospitalizations
1 year
Resources use:
care payer
sectional Dhabi: 67% men;
addressed, and
Micro- and
due to diabetes
interviewer48% nationals;
sensitivity analyses
macrovascular
complications, and
administered
33%: >60 years old)
not conducted
complications:
emergency room
questionnaire
US$15,104
visits due to
completed by
($18,959 adjusted
diabetes)
patients
to 2015)
Approach: marcoCost drivers:
costing
diabetes-related
complications;
treatment with
insulin

Study
design

Sample size

Data sources

Cost components
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overall rate of 4.8 per 1,000 person-years (PY), with its
highest rates being seen in those aged 55 to 59 years (23.4
and 32.4 per 1,000 PY for men and women, respectively)
[13]. That study also shows that the incidence rates of diabetes among women remarkably increase after the age of
40, becoming almost double the corresponding rates for men
(6.3 versus 3.3 per 1,000 PY, respectively).
4.5. Prehypertension and Hypertension. One study addressed
the prevalence of hypertension in 5 emirates and reported an
overall estimate of 31% for hypertension prevalence in adults
[42]. Hypertension was deﬁned as having a history of known
and treated hypertension, having a systolic blood pressure
equal to or above 140 mm·Hg, or having diastolic blood
pressure equal to or above 90 mm·Hg [42]. At an emiratespeciﬁc level, only one study addressed the prevalence of
hypertension in the Emirati adults of Sharjah, reporting an
ASR of 37% [39], which is much higher than rates reported
by the two studies addressing hypertension prevalence in
Abu Dhabi’s Emirati adults (21% in the older study [40] and
29% in the more recent one [25]). However, despite the
increase in the overall estimates of hypertension in Abu
Dhabi reported by the two latter studies (from 21% to 29%),
it is diﬃcult to accurately state whether this increase truly
reﬂects an uptrend in hypertension prevalence, given the
diﬀerences in the methodologies adopted by the two studies
and the deﬁnitions used for elevated blood pressure. Interestingly, however, a higher prevalence of hypertension is
noted in males compared to females in all three aforementioned studies [20, 39, 43]. As for the paediatric

Perspective

population, only one study addressed the prevalence of
hypertension and reported that more than one-quarter of
the Emirati schoolchildren residing in Abu Dhabi have elevated blood pressure (11% prehypertensive and 17% hypertensive, with a predominance of systolic hypertension in
the hypertensive children) [42].
4.6. Cardiometabolic Disorders in the Working Class.
Only two of the included studies addressed the prevalence of
cardiometabolic disorders in adult employees in particular
[45, 46]. The older study reported a prevalence of 74% for
dyslipidemia and 68% for obesity in both national and expatriate male workers [45]. In contrast, the more recent study
compared the rates of cardiometabolic disorders in oil and gas
company male workers of Abu Dhabi prior to employment to
rates seen at postemployment periodic health evaluations
[46]. It demonstrated an increase in hypertension and diabetes rates by about 20% and 9%, respectively, with a decline
in obesity rates by almost one-half (from 16.6% to 8.6% from
preemployment to postemployment), all occurring within 3
years of employment [46].
Assessment of the included studies revealed that onethird of them had a medium overall risk of bias (11/35), and
the remaining ones had a low risk of bias (24/35). The most
commonly encountered defects in the included studies were
failing to recruit truly representative samples of the target
population (n � 21), employing a nonrepresentative sampling frame (n � 11), and recruiting nonrandom
(i.e., convenient) samples (n � 9). Table 3 summarizes the
risk of bias assessment for the included studies.
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4.7. Cost of Illness (COI) for Diabetes. Only one of the included studies addressed the COI for diabetes, one of the
cardiometabolic disorders of interest to us [12]. This crosssectional study, which was conducted in 2004, adopted
a health care-payer perspective that accounted for all the
direct medical costs of diabetes for Emirati and non-Emirati
patients attending the outpatient clinics at the two major
referral hospitals (i.e., Al Ain and Tawam) regardless of age
or sex. Table 4 summarizes the characteristics and results of
the study. In short, using a macro-cost approach, the study
estimates the annual cost of diabetes to be around US$1,605
for patients with complication-free cases ($2,015 adjusted for
the year 2015). In contrast, this value almost doubles for
patients with microvascular complications, increases by
more than sixfold for those with macrovascular complications, and increases by more than ninefold for those with
concomitant micro- and macrovascular complications [12].
However, the study’s limited reporting of cost estimates, its
failure to identify major uncertainties or perform any
sensitivity analyses, and its insuﬃcient documentation and
justiﬁcation for its reported estimates render its overall
methodological quality of the suboptimal level (Appendix B
in Supplementary Materials).

5. Discussion
This systematic review provides an overview of the prevalence of major cardiometabolic disorders in the UAE,
namely, overweight and obesity, metabolic syndrome,
dyslipidemia, diabetes, and hypertension.
The last study conducted to date at the national level in
the UAE addressing overweight and obesity prevalence in
Emirati and non-Emirati adults reported that the overall
prevalence rates for overweight and obesity are 40% and
33%, respectively, showing that almost three-quarters of the
UAE’s adults (73%) have a body mass index (BMI)
≥25 kg/m2 [47]. This somewhat mirrors the combined
overall rates for overweight and obesity seen in the United
States during the same period (64.5%) [42]. However, a more
recent study by Yusufali et al. estimates that 62% of the
UAE’s adults have a BMI ≥25 kg/m2, based on data collected
from ﬁve emirates in 2012, suggesting a slight drop in obesity
and overweight rates [42]. In fact, the overall estimates of
overweight and obesity reported by the study (42% and 20%,
respectively) [42] are clearly lower than those reported for
earlier years [18]. However, it remains rather imprecise to
deduce any trends in overweight or obesity rates by simply
comparing the two studies due to their major diﬀerences
with regard to design, sample recruitment, and specimen
analysis. Nonetheless, the UAE still appears to be doing
better than several of its neighbouring countries with regard
to its overweight and obesity rates, such as Oman or Saudi
Arabia (ASR of 64.7% and 63.6%, respectively) [48, 49].
The World Health Organization’s (WHO) more recent
report on NCD prevalence demonstrates high rates of
overweight and obesity in the UAE’s adults, reporting
similar estimates for the two sexes (75.8% in female and
73.1% in male) [48]. Such national-level estimates in the
UAE mirror the combined rates reported by one of our
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included studies for overweight and obesity in each sex
among the Emirati adults residing in Abu Dhabi (overweight
ASR: 34.4% in men and 33.6% in women, added to obesity
ASR: 41.5% in men and 40.7% in women) [20]. This is
possibly due to Abu Dhabi’s (UAE capital) dense population
and prominent role in the country’s economic and political
status, somewhat rendering it a miniature representative
version of the entire country. The aforementioned study
highlights that while the two sexes in the UAE have almost
equal rates of overweight and obesity, their counterparts in
the United States (US) have an almost 10% diﬀerence in
these rates (75% in men versus 66.5% in women) [50]. More
extremely, Oman shows an almost 10-fold higher ASR for
obesity in its women compared to men (44.3% versus 4.7%,
respectively) [51]. This is likely because the rates of overweight and obesity across the two sexes remarkably diﬀer by
region, depending primarily on diﬀerences in social and
cultural values, as highlighted in the 2011 global survey [52].
As for trending the rates of overweight and obesity in the
UAE, only one study included in our review reports an
observed uptrend of about 35% in the Emirati women residing in the Al Ain city of Abu Dhabi between 2000 and
2004, without reporting any trends for rates in men [34]. In
fact, none of the included studies addresses the trends in
overweight and obesity rates in men, another issue highlighted by the global survey as well [52].
As for the metabolic syndrome, only one included study
addressed the national prevalence of metabolic syndrome
among the UAE’s adults between 1999 and 2000, reporting
overall rates of 38% (as per NCEP deﬁnition) and 41% (IDF
deﬁnition). The study also highlights remarkable diﬀerences
in the sex-speciﬁc estimates of metabolic syndrome,
reporting higher rates for women (47% and 46% as deﬁned
by the NCEP and IDF, respectively) compared to men (32%
and 33% as deﬁned by the NCEP and IDF, respectively) [17].
In contrast, the overall prevalence of metabolic syndrome in
Oman as deﬁned by the IDF was only 19.8% in 2006, almost
half of that in the UAE [53]. Interestingly, however, the
Omani study highlights even more pronounced diﬀerences
in the sex-speciﬁc ASRs for metabolic syndrome (18.4% in
men versus 40% in women) [53] compared to those in the
UAE. This clearly demonstrates much lower rates of metabolic syndrome in Omani males compared to their UAE
counterparts (18.4% versus 33%), as opposed to the almost
equal rates seen across Omani and UAE females (40% and
46%, respectively) [17]. In contrast, Saudi Arabia’s overall
ASR for metabolic syndrome was reported to be 39.3%
between 1995 and 2000, as deﬁned by NCEP [54], which is
almost similar to the UAE’s 1999-2000 estimate (41%).
Likewise, the sex-speciﬁc ASRs for metabolic syndrome
reported for the two sexes in Saudi Arabia also mirror those
of men and women in the UAE using the NCEP deﬁnition
(37.2% and 42% in Saudi Arabia’s men and women, respectively, versus 32% and 47% in the UAE’s men and
women, respectively) [54].
Regarding dyslipidemia, there is an uptrend in the
overall dyslipidemia rates in the UAE in recent years. A 2012
study included in our review addressed Emirati adults residing in Abu Dhabi and reported an ASR of 50.7% for
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dyslipidemia [20]. Another study conducted 3 years later
reported a higher overall estimate of 68.5% for dyslipidemia
prevalence among the adults in ﬁve of the UAE’s emirates
[42]. However, while the former study highlights remarkable
diﬀerences in the sex-speciﬁc rates of dyslipidemia,
reporting crude rates of 57.7% in men versus 33.9% in
women [20], the more recent study does not break its overall
estimate into sex-speciﬁc rates, making us unable to trend the
sex-speciﬁc rates of dyslipidemia in recent years. In contrast,
despite its higher rates of overweight and obesity, Saudi
Arabia paradoxically has a lower overall rate of dyslipidemia
(44%) compared to the UAE (68.5%), as reported by a national Saudi study published in the same year [55]. As for the
sex-speciﬁc rates of the individual components of dyslipidemia in Saudi Arabia, the latter study reported similar rates
of hypercholesterolemia and elevated low-density lipoprotein
cholesterol (LDL-C) levels in both sexes (18.7% and 30.7% in
men and 19.9% and 29.8% in women, respectively), with
signiﬁcantly higher rates of low HDL-C levels in men
compared to women (33.7% versus 17.7%, respectively; p
value � 0.001) [55]. A national study conducted in Kuwait,
another neighbouring country to the UAE, addressed the
temporal trends in hypercholesterolemia rates deﬁned
according to the NCEP criteria from 1998 through 2009 [49].
The study clearly reported a progressive increase in the sexspeciﬁc rates of hypercholesterolemia, reaching 56% and
53.6% in men and women, respectively, in 2007, followed by
a signiﬁcant drop thereafter to 33.7% and 30.6%, respectively,
in 2009 [49]. However, given that the prevalence rates of
hypercholesterolemia, high LDL-C levels, or low HDL-C
levels were collectively reported as “dyslipidemia” in the
studies conducted in the UAE, we were unable to compare the
speciﬁc rates of each of those lipid entities in the UAE to their
corresponding estimates in nearby countries.
Only one included study addressed the prevalence of
diabetes at the national level in the adult population of the
UAE, reporting an overall ASR of 21% for diabetes and 7%
for impaired fasting glucose between 1999 and 2000 [18].
These values are clearly higher than those reported in the US
during the same time interval (1999-2000; 8.6% and 6.2%,
respectively) [56], highlighting remarkably higher rates of
diabetes in the UAE compared to the US (21% versus 8.6%,
respectively), despite similar rates of impaired fasting glucose (7% versus 6.2%, respectively). However, both studies
report similar ASR of diabetes in men and women, although
the overall rates reported in the UAE (20.4% and 22.3%,
respectively) are higher than those seen in the US (9.3% and
8.1%, respectively) [56]. In contrast, impaired fasting glucose
rates are remarkably higher in women compared to men in
the UAE (7.2% versus 4.5%, respectively) [18], which is the
complete opposite of what is seen in the US where the ASR
for impaired fasting glucose in men is almost double that in
women (8.3% versus 4.5%, respectively) [56].
Furthermore, a more recent study included in our review
reports ASR of 29.5% and 24.6% for prediabetes and diabetes,
respectively. Taken together, these rates suggest that more
than half of the Emirati adults of Abu Dhabi suﬀer from
impaired glycemic control [20]. However, no diﬀerences were
noted across the sex-speciﬁc rates reported by that study.
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These ﬁndings should alarm public health policy-makers in
the UAE and should highlight the need for prompt intervention to curb the high rates of impaired glycemic control
in the UAE in order to prevent further progression into
diabetes [57]. Additionally, it is important to draw attention
to the 2011 IDF statistics which rank Kuwait ﬁrst in the world
with regard to its high national prevalence of type 2 diabetes
(21.2%), followed by Qatar (20.1%), Saudi Arabia (20.0%), and
Bahrain (19.8%), all of which happen to fall in the immediate
vicinity of the UAE [58]. This clearly shows a regional pooling
of diabetes along the western banks of the Arabian Gulf,
possibly due to underlying common genetic and/or ethnic
backgrounds of the citizens in those countries, added to the
possible roles of their similar environmental, social, and dietary factors as well.
Hypertension also falls among the UAE’s predominant
cardiometabolic disorders, with all relevant studies conducted
to date reporting emirate-speciﬁc estimates rather than national ones [20, 39, 42]. Thus, we refer to the WHO 2014
global status report on NCDs that found an overall ASR of
26.3% for elevated blood pressure in the UAE and almost
similar rates across the two sexes (27.5% in men and 23.3% in
women) [48]. In contrast, Dubai Health Authority (DHA)
and Dubai Statistics Center (DSC) collaboratively gathered
data on the prevalence of various cardiovascular risk factors
including hypertension between 2014 and 2016 and reported
an overall estimate of 18.9% for hypertension prevalence
among the Emirati citizens of Dubai [59]. The study also
reports similar rates across the two sexes (20% in men and
18% in women). Another emirate-speciﬁc study run by the
Health Authority of Abu Dhabi (HAAD) 3 years earlier than
the latter study reports an overall prevalence of 17% for
hypertension among Abu Dhabi’s Emirati citizens compared
to double that prevalence (35%) in its non-Emirati citizens
[60]. However, contrary to the similar sex-speciﬁc rates of
hypertension reported in the Dubai study [59], HAAD
highlighted a signiﬁcant diﬀerence in the rates of hypertension across the two sexes in Abu Dhabi, reporting a twofold
higher rate in Emirati men (24%) compared to women (12%)
[60]. Saudi Arabia shares similar estimates with its UAE
neighbour, reporting an almost identical overall prevalence
rate of hypertension among its adults (25.5%) in 2011 [61]. In
contrast, Oman, another country bordering the UAE, reports
almost double that rate for adult hypertension, giving
a strikingly high estimate of 41.5% in 2015 [62]. However,
Yemen, a country bordering each of Saudi Arabia, Oman, and
the UAE, reported a remarkably much lower overall ASR of
hypertension than any of its neighbours in 2013 (7.7%) [63].
Such ﬁndings pose a question on the factors that play a major
role in the development of hypertension, given that its rates in
geographically proximal, culturally similar, and ethnically
related countries are remarkably diﬀerent as shown previously. This also contradicts with the apparent pooling of
diabetes in that same geographical area, as highlighted earlier.
Our review had some limitations worthy of being
addressed. For instance, costs associated with cardiometabolic disorders in the UAE were not properly reported due to the lack of relevant studies. Moreover, the
overall quality of some national studies limited our ability to
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provide conclusive evidence about the trend of cardiometabolic disorders.

6. Conclusions
However, our systematic review’s major strength is its highly
sensitive search strategy that possibly covered all relevant
and intended literatures adequately. Moreover, our adherence to standardized and validated methods in conducting
the review [10], our transparency in disseminating our
search strategy (Appendix A in Supplementary Materials),
and our use of standardized and previously tested data
extraction and risk of bias assessment tools further support
the review, increasing conﬁdence in its reported ﬁndings.
We are also the ﬁrst team of researchers to conduct a systematic review of the epidemiology of obesity and cardiometabolic disorders in the UAE, setting grounds for
subsequent researchers to build on. Thus, the ultimate aim of
this review was to simply provide insights into the current
prevalence rates and associated costs of cardiometabolic
disorders in the UAE, making local decision-makers better
informed and therefore capable of altering and tailoring
future health policies accordingly.
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